Filing
Spy
Filing
Spy
Home
About
RCKT
Rocket Pharmaceuticals Inc
Biotechnology company developing gene therapies for rare diseases
CUSIP: 77313F106
Healthcare
US
1 holder
Ownership
Activity
2023 Q4
9 of 19 quarters
Total Value
$120.90M
Total Shares
4.03M
Net Share Change
-1.60M
Activity
1 selling
Investor
Value
Shares
Weight
Change
Maverick Capital
$120.90M
4.03M
2.4%
TRIM
-1.60M
(-28.3%)
Maverick Capital
$120.90M
4.03M shares
TRIM
-1.60M
(-28.3%)
RCKT — Rocket Pharmaceuticals Inc - FilingSpy